Fundraising Fox
🦊/Companies
Sign in

Enzyre

Eindhoven, NL · 5 known investors

Find your way into Enzyre

6 people in our graph share verified history with the Enzyre team — schools, employers, funds. One of them is your warm intro.

Jan Van den Bergheunlockedknows Wim van den Broek · together at Enzyre B.V. (overlapped)
×4knows the team · via Nivra
knows the team · via Enzyre B.V.

Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care. The device aims to enable rapid therapy adjustment for patients and reduce healthcare costs by bringing laboratory testing capabilities to clinical settings.

BiotechDeep TechDigital HealthHealthtechMedical Devices

Founders & leadership

WVWim van den Broek
Wim van den BroekinCEOWim van den Broek is CEO of Enzyre, which develops a handheld diagnostic device for blood coagulation testing at the point of care. He has experience in general and financial management.
W
WaanderCSO

Investors · 5

Novalis BiotechGhent
i&i Biotech FundreportedPrague · $150K – $2M
Oost NLreported · 2 sourcesApeldoorn · $108K – $5.4M
Takeda VenturesreportedCambridge · $1M – $5M

Also in the syndicate · 1

Demcon Investment

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Dutch Company Raises Over $12 Million for Development of Home-based Blood Coagulation Test | Managed Healthcare Executivemanagedhealthcareexecutive.com · May 2026Enzyre Closes €12 Million Series A Funding Round | Medical Product Outsourcingmpo-mag.com · Jan 2023Enzyre uses investments to save thousands on healthcare - Noviotech Campusnoviotechcampus.com · Dec 2022Enzyre raises funds for haemophilia diagnostic platform developmentmedicaldevice-network.com · Nov 2022Enzyre closes Series A financing round of EUR 12M to advance pioneering diagnostic technology platform for hemophilia patientsprnewswire.com · Nov 2022Enzyre Receives €1.4M Corona Bridge Loan - FinSMEsfinsmes.com · Jul 2020

Frequently asked questions

What does Enzyre do?
Enzyre develops a handheld diagnostic device that performs multiple blood coagulation assays in parallel to identify bleeding causes at the point of care. The device aims to enable rapid therapy adjustment for patients and reduce healthcare costs by bringing laboratory testing capabilities to clinical settings.
Who are Enzyre's investors?
Enzyre's investors include Novalis Biotech, i&i Biotech Fund, Oost NL, Takeda Ventures.
Where is Enzyre headquartered?
Enzyre is headquartered in Eindhoven, NL.